Contrasting Taylor Wimpey (OTCMKTS:TWODF) & Zepp Health (NYSE:ZEPP)

Zepp Health (NYSE:ZEPP) and Taylor Wimpey (OTCMKTS:TWODF) are both consumer discretionary companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

Analyst Recommendations

This is a summary of recent ratings and price targets for Zepp Health and Taylor Wimpey, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zepp Health	1	0	1	0	2.00
Taylor Wimpey	3	1	2	0	1.83

Zepp Health currently has a consensus price target of $53.01, indicating a potential upside of 879.85%. Given Zepp Health’s stronger consensus rating and higher possible upside, research analysts clearly believe Zepp Health is more favorable than Taylor Wimpey.

Earnings and Valuation

This table compares Zepp Health and Taylor Wimpey”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zepp Health	$258.90 million	0.31	-$40.07 million	($2.52)	-2.15
Taylor Wimpey	N/A	N/A	N/A	$0.09	12.68

Taylor Wimpey has lower revenue, but higher earnings than Zepp Health. Zepp Health is trading at a lower price-to-earnings ratio than Taylor Wimpey, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

52.6% of Zepp Health shares are owned by institutional investors. Comparatively, 39.9% of Taylor Wimpey shares are owned by institutional investors. 36.0% of Zepp Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Zepp Health and Taylor Wimpey’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zepp Health	-14.70%	-15.64%	-6.03%
Taylor Wimpey	N/A	N/A	N/A

Summary

Taylor Wimpey beats Zepp Health on 6 of the 11 factors compared between the two stocks.

About Zepp Health

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals. The company offers smart bands, watches, modules, and scales; and associated accessories, smart hearable products, sportswear, home fitness equipment, home appliances, and smart watch accessories. It also provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. It offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.

About Taylor Wimpey

Taylor Wimpey plc operates as a homebuilder in the United Kingdom and Spain. It builds and delivers various homes and communities. Taylor Wimpey plc was incorporated in 1935 and is based in High Wycombe, the United Kingdom.